Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Vascular Diseases

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beranek, J; Binkert, CA; Eckhardt, B; Froehlich, JM; Gutzeit, A; Jenelten, R; Wentz, KU; Willemse, E1
Bautz, W; Dobritz, M; Fellner, C; Fellner, F; Janka, R; Lang, W; Lenz, M1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Vascular Diseases

ArticleYear
Clinical experience in timed arterial compression contrast-enhanced magnetic resonance angiography of the hand.
    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2010, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Hand; Heterocyclic Compounds; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Radial Artery; Reproducibility of Results; Retrospective Studies; Ulnar Artery; Vascular Diseases; Young Adult

2010
Gd-BOPTA: "the MRA contrast agent of choice"?
    Rontgenpraxis; Zeitschrift fur radiologische Technik, 1999, Volume: 52, Issue:2

    Topics: Aortic Valve Stenosis; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Subclavian Artery; Vascular Diseases

1999